methadyl acetate has been researched along with Opioid-Related Disorders in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (32.88) | 18.7374 |
1990's | 10 (13.70) | 18.2507 |
2000's | 34 (46.58) | 29.6817 |
2010's | 5 (6.85) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bochner, F; Newcombe, DAL; Somogyi, AA; White, JM | 1 |
Amato, L; Bellisario, C; Davoli, M; Minozzi, S | 1 |
Chopra, MP; Feldman, Z; Mancino, MJ; Oliveto, A | 1 |
Finkbeiner, T; Gastpar, M; Heinrich, C; Heitkamp, R; Poehlke, T; Scherbaum, N; Wolstein, J | 1 |
Amato, L; Davoli, M; Minozzi, S | 1 |
Czock, D; Hameister, J; Keller, F; Mitzner, S; Tiefenbach, B | 1 |
Cohen, J | 1 |
Choo, RE; Dams, R; Gray, TR; Huestis, MA; Jones, HE | 1 |
Gordon, MS; Gryczynski, J; Kelly, SM; Kinlock, TW; O'Grady, KE; Schwartz, RP | 1 |
Kreek, MJ; Vocci, FJ | 1 |
Dunlop, A; Lintzeris, N; Muhleisen, P; Ritter, A | 1 |
Compton, M; Ling, W; Rawson, RA | 1 |
Ishøy, T; Iversen, C | 1 |
Dietze, P; Lenné, MG; Redman, JR; Rumbold, GR; Triggs, TJ | 1 |
Horst, DA; Humphreys, K; Minkel, JD; Oliva, EM; Trafton, JA | 1 |
Krantz, MJ; Mehler, PS | 1 |
Digiusto, E; Mattick, RP; O'Brien, S; Ritter, A; Shakeshaft, A | 1 |
Bochner, F; Newcombe, DA; Somogyi, AA; White, JM | 1 |
Gonsai, KR; Kosten, TR; McCance-Katz, EF; Oliveto, A; Poling, J; Sevarino, KA; Stine, SM | 1 |
Acri, J; Elkashef, A; Vocci, FJ | 1 |
Beilenson, P; Bishai, D; Cornelius, L; Havens, JR; Huettner, S; Latkin, CA; Lloyd, JJ; Rapp, C; Ricketts, EP; Strathdee, SA | 1 |
Bigelow, GE; Johnson, RE; Marsch, LA; Mudric, T; Stephens, MA; Strain, EC | 1 |
Clark, NC; Dietze, P; Lenné, MG; Redman, JR | 1 |
Fairbairn, N; Kerr, T; Maas, B; Montaner, J; Wood, E | 1 |
Bigelow, GE; Brooner, RK; Johnson, RE; Lott, DC; Strain, EC | 1 |
Humphreys, K; Oliva, EM; Tracy, SW; Trafton, JA | 1 |
Arnsten, JH; Gourevitch, MN; Kunins, HV; Whitley, SD | 1 |
Bigelow, GE; Haigney, MC; Johnson, RE; Nuzzo, PA; Wedam, EF | 1 |
Franklin, L'; Schrott, LM; Serrano, PA | 1 |
Tennant, FS | 1 |
Baskerville, JC; Brands, B; Gowdey, CW; Hirst, M | 1 |
Geyer, G; Resnick, RB; Washton, AM | 1 |
Hough, G; Resnick, RB; Washton, AM | 1 |
Senay, EC | 1 |
Ellingboe, J; Goldstein, A; Judson, BA; Mendelson, JH | 1 |
Karp-Gelernter, E; McCabe, OL; Savage, C | 1 |
Garwood, J; Perzel, J; Resnick, RB; Washton, AM | 1 |
Blaine, JD; Renault, PR; Thomas, DB; Whysner, JA | 1 |
Khazan, N; Steinfels, GF; Young, GA | 1 |
Steinfels, GF; Young, GA | 1 |
Lichtblau, L; Sparber, SB | 2 |
Kuwahara, MD; Sparber, SB | 1 |
Khazan, N; Lukas, SE; Moreton, JE | 1 |
Goldstein, A; Himmelberger, DU; Judson, BA | 2 |
Kacian, J; Marcovici, M; McLellan, AT; O'Brien, CP | 1 |
Kreek, MJ | 1 |
Nightingale, SL | 1 |
Jasinski, DR; Vaupel, DB | 1 |
Chalmers, T; Glanz, M; Klawansky, S; McAullife, W | 1 |
Hasson, AL; Huber, AM; Ling, W; McCann, MJ; Rawson, RA | 1 |
Bigelow, GE; Eissenberg, T; Johnson, RE; Jones, HE; Stitzer, ML; Strain, EC; Walsh, SL | 1 |
Farren, C; Kosten, TR; Oliveto, AH | 1 |
Wartenberg, AA | 1 |
Bigelow, GE; Chutuape, MA; Johnson, RE; Stitzer, ML; Strain, EC; Walsh, SL | 1 |
O'Connor, PG | 1 |
Ege, PP; Petersen, H; Skauge, L; Svejsø, J | 1 |
Schwetz, BA | 1 |
Stimmel, B | 1 |
Friedland, G; Jatlow, P; Kosten, TR; McCance-Katz, EF; Rainey, PM | 1 |
Camí, J; Farré, M; Mas, A; Moreno, V; Torrens, M | 1 |
Battjes, RJ; Kinlock, TW; Schwartz, RP | 1 |
Ali, RL; Gowing, LR; White, JM | 1 |
Barnes, TB; Masten, LW | 1 |
Howd, RA; Pryor, GT | 1 |
Desmond, DP | 1 |
Masten, LW | 1 |
Fraser, AD | 1 |
Walton, RG | 1 |
Pumphrey, E; Rawson, RA; Seecof, R; Tennant, FS | 1 |
13 review(s) available for methadyl acetate and Opioid-Related Disorders
Article | Year |
---|---|
Maintenance treatments for opiate -dependent adolescents.
Topics: Adolescent; Buprenorphine; Humans; Maintenance Chemotherapy; Methadone; Methadyl Acetate; Naloxone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2014 |
Maintenance treatments for opiate dependent adolescent.
Topics: Adolescent; Buprenorphine; Humans; Methadone; Methadyl Acetate; Naloxone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Young Adult | 2009 |
History and current status of opioid maintenance treatments: blending conference session.
Topics: Buprenorphine; Clinical Trials as Topic; History, 20th Century; Humans; Methadone; Methadyl Acetate; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2002 |
Treating opioid dependence. Growing implications for primary care.
Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Europe; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders; Prevalence; Primary Health Care; Substance Withdrawal Syndrome; United States | 2004 |
Medication development for addictive disorders: the state of the science.
Topics: Animals; Buprenorphine; Chemistry, Pharmaceutical; Clinical Trials as Topic; Cocaine-Related Disorders; Dopamine; Drug Design; Drug Industry; Drug Therapy, Combination; Humans; Methadyl Acetate; Naloxone; National Institutes of Health (U.S.); Opioid-Related Disorders; Program Development; Secondary Prevention; Substance-Related Disorders; United States | 2005 |
Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.
Topics: Animals; Anti-HIV Agents; Buprenorphine; Drug Interactions; Humans; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2006 |
Clinical status of methadyl acetate (LAAM).
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Humans; Kinetics; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders | 1981 |
Biological correlates of methadone maintenance pharmacotherapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Chromatography, Gas; Cocaine; Heroin Dependence; Humans; Illicit Drugs; Infant, Newborn; Methadone; Methadyl Acetate; Morphine Dependence; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Time Factors | 1994 |
Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
Topics: Adult; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 1997 |
Treatment considerations in the opioid dependent patient.
Topics: Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders; Treatment Outcome | 1999 |
[New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
Topics: Analgesics, Opioid; Buprenorphine; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Methadyl Acetate; Narcotic Antagonists; Opioid-Related Disorders | 2000 |
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
Topics: Buprenorphine; Humans; Methadone; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Patient Dropouts; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome | 2002 |
Clinical toxicology of drugs used in the treatment of opiate dependency.
Topics: Buprenorphine; Clonidine; Humans; Methadone; Methadyl Acetate; Naltrexone; Opioid-Related Disorders | 1990 |
15 trial(s) available for methadyl acetate and Opioid-Related Disorders
Article | Year |
---|---|
Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patients.
Topics: Adult; Drug Tolerance; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Psychomotor Performance; Time Factors; Young Adult | 2017 |
A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
Topics: Adult; Analgesics, Opioid; Europe; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Pain Measurement; Severity of Illness Index; Sex Factors; Spirometry; Survival Analysis; Young Adult | 2009 |
The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving.
Topics: Adult; Automobile Driving; Buprenorphine; Drug Combinations; Ethanol; Female; Humans; Male; Methadone; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Victoria | 2003 |
Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2004 |
Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
Topics: Adult; Ambulatory Care; Analgesics, Opioid; Cocaine; Cocaine-Related Disorders; Connecticut; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2005 |
Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.
Topics: Adult; Baltimore; Behavior Therapy; Case Management; Community Mental Health Services; Female; Health Services Accessibility; HIV Seroprevalence; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Motivation; Narcotics; Needle-Exchange Programs; Opioid-Related Disorders; Patient Acceptance of Health Care; Referral and Consultation; Substance Abuse, Intravenous; Transportation; Urban Population | 2006 |
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Prospective Studies; Receptors, Opioid, mu; Regression Analysis; Treatment Outcome | 2005 |
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
Topics: Adult; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Risk-Taking | 2006 |
Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Clinical Trials as Topic; Clonidine; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1983 |
Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study.
Topics: Adult; Clinical Trials as Topic; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Random Allocation | 1982 |
Clinical status of methadyl acetate (LAAM).
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Humans; Kinetics; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders | 1981 |
Induction with levomethadyl acetate: safety and efficacy.
Topics: Adult; Analgesics, Opioid; Attitude to Health; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadyl Acetate; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Substance Abuse Detection; Surveys and Questionnaires; Treatment Outcome | 1998 |
Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Pilot Projects; Substance Withdrawal Syndrome | 1998 |
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2000 |
A novel opioid maintenance program for prisoners: preliminary findings.
Topics: Adult; Humans; Male; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Pilot Projects; Prisoners; Secondary Prevention | 2002 |
46 other study(ies) available for methadyl acetate and Opioid-Related Disorders
Article | Year |
---|---|
Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Methadyl Acetate; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Retrospective Studies; Sex Characteristics; Substance Withdrawal Syndrome | 2008 |
Levomethadone is poorly removed by the molecular adsorbents recirculating system.
Topics: Adult; Humans; Male; Metabolic Clearance Rate; Methadyl Acetate; Opioid-Related Disorders; Renal Dialysis; Sorption Detoxification | 2009 |
No opiate substitutes for the masses of IDUs.
Topics: Female; Harm Reduction; HIV Infections; Humans; Male; Methadone; Methadyl Acetate; Narcotics; Needle-Exchange Programs; Opioid-Related Disorders; Russia; Substance Abuse, Intravenous; Ukraine | 2010 |
Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence.
Topics: Chromatography, Liquid; Female; Humans; Hydrogen-Ion Concentration; Mass Spectrometry; Methadone; Methadyl Acetate; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pyrrolidines; Saliva | 2011 |
Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.
Topics: Adult; Analgesics, Opioid; Baltimore; Crime; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Patient Compliance; Prisoners; Proportional Hazards Models; Treatment Outcome; Young Adult | 2012 |
Training primary health care professionals to provide buprenorphine and LAAM treatment.
Topics: Buprenorphine; Education, Medical, Continuing; Education, Pharmacy, Continuing; Humans; Methadyl Acetate; Opioid-Related Disorders; Pharmacists; Physicians, Family; Professional Competence; Quality of Health Care; Receptors, Opioid | 2002 |
Clinical treatment of opioid addiction and dependence.
Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Humans; Inactivation, Metabolic; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2003 |
[Substitutions therapy of opiate addiction in Denmark].
Topics: Benzodiazepines; Buprenorphine; Denmark; Humans; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Surveys and Questionnaires | 2003 |
Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; Health Services; Health Services Needs and Demand; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Methadone; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Pain; Pain Measurement; Statistics as Topic; Substance-Related Disorders; United States; Utilization Review; Veterans | 2004 |
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2004 |
Effect of opioid substitution therapy on alcohol metabolism.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Female; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2006 |
Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
Topics: Adult; Alcoholism; Child; Child of Impaired Parents; Cocaine-Related Disorders; Combined Modality Therapy; Counseling; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Guideline Adherence; Heroin Dependence; Hospitals, Veterans; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Dropouts; Substance Abuse Detection; Treatment Outcome; United States; Veterans | 2007 |
Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
Topics: Adult; Ambulatory Care; Buprenorphine; Counseling; Delivery of Health Care, Integrated; Female; Health Services Accessibility; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Naloxone; Narcotics; New York City; Opioid-Related Disorders; Outcome Assessment, Health Care; Patient Care Team; Patient Dropouts; Social Work; Substance Abuse Detection | 2007 |
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training.
Topics: Analgesics, Opioid; Animals; Brain-Derived Neurotrophic Factor; Down-Regulation; Drug Administration Schedule; Female; Hippocampus; Learning; Male; Maze Learning; Methadyl Acetate; Neuronal Plasticity; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptor, trkB; Substance Withdrawal Syndrome | 2008 |
(-)-alpha-Acetylmethadol for treatment of chronic pain patients who abuse opioids.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Pain | 1983 |
Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Codeine; Delayed-Action Preparations; Heroin; Humans; Hydromorphone; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Rats; Substance Withdrawal Syndrome; Zinc | 1980 |
Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy.
Topics: Ambulatory Care; Female; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Sex Factors | 1983 |
Methadone maintenance: an update.
Topics: Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 1983 |
Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
Topics: Adult; Humans; Luteinizing Hormone; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Pituitary Gland; Radioimmunoassay; Substance Withdrawal Syndrome; Testosterone | 1984 |
LAAM instead of take-home methadone.
Topics: Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 1982 |
Narcotic abstinence in dependent rats: EEG and behavioral correlates.
Topics: Animals; Behavior, Animal; Electroencephalography; Female; Humans; Methadone; Methadyl Acetate; Morphine; Opioid-Related Disorders; Rats; Sleep, REM; Substance Withdrawal Syndrome | 1980 |
Effects of narcotic abstinence on schedule-controlled behavior in dependent rats.
Topics: Animals; Conditioning, Operant; Female; Humans; Methadyl Acetate; Morphine; Opioid-Related Disorders; Rats; Reinforcement Schedule; Substance Withdrawal Syndrome; Time Factors | 1981 |
Opiate withdrawal in utero increases neonatal morbidity in the rat.
Topics: Animals; Drug Tolerance; Embryo Implantation; Female; Fetal Death; Humans; Litter Size; Methadone; Methadyl Acetate; Naloxone; Opioid-Related Disorders; Pregnancy; Pregnancy, Animal; Rats; Substance Withdrawal Syndrome | 1981 |
Prenatal withdrawal from opiates interferes with hatching of otherwise viable chick fetuses.
Topics: Animals; Chick Embryo; Humans; Methadone; Methadyl Acetate; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1981 |
Outcome of pregnancy in rats chronically exposed to 1-alpha-acetylmethadol (LAAM).
Topics: Animals; Animals, Newborn; Birth Weight; Body Weight; Female; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders; Pregnancy; Pregnancy, Animal; Rats; Time Factors | 1981 |
Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.
Topics: Animals; Behavior, Animal; Drug Tolerance; Electroencephalography; Female; Humans; Methadone; Methadyl Acetate; Morphine; Opioid-Related Disorders; Rats; Rats, Inbred Strains | 1982 |
The naloxone test for opiate dependence.
Topics: Humans; Injections, Intramuscular; Injections, Intravenous; Methadyl Acetate; Naloxone; Naltrexone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1980 |
A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.
Topics: Adult; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Outcome and Process Assessment, Health Care | 1981 |
Levomethadyl acetate to be used in narcotic treatment programs.
Topics: Drug Approval; Humans; Methadyl Acetate; Opioid-Related Disorders | 1993 |
From the Food and Drug Administration.
Topics: Clinical Trials as Topic; Drug Approval; Federal Government; Female; Government Regulation; Guidelines as Topic; Humans; Male; Methadyl Acetate; Opioid-Related Disorders; Patient Selection; Pregnant Women; Research Subjects; Risk Assessment; Sex Factors; United States; United States Food and Drug Administration | 1993 |
l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
Topics: Analgesics, Opioid; Animals; Dogs; Dose-Response Relationship, Drug; Methadone; Methadyl Acetate; Morphine; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1997 |
A 3-year progress report on the implementation of LAAM in the United States.
Topics: Female; Humans; Male; Methadyl Acetate; Narcotics; Opioid-Related Disorders; United States | 1998 |
Treating opioid dependence--new data and new opportunities.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2000 |
From the Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Aristolochic Acids; Arrhythmias, Cardiac; Cytomegalovirus Retinitis; Dietary Supplements; Drug Labeling; Ganciclovir; Humans; Kidney Diseases; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Phenanthrenes; Phytotherapy; Prodrugs; United States; United States Food and Drug Administration; Valganciclovir | 2001 |
FDA changes labeling for opiate addiction drug.
Topics: Arrhythmias, Cardiac; Contraindications; Drug Labeling; Humans; Methadyl Acetate; Narcotics; Opioid-Related Disorders; United States; United States Food and Drug Administration | 2001 |
Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Topics: Buprenorphine; Electrocardiography; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Time Factors | 2001 |
Effect of opioid dependence pharmacotherapies on zidovudine disposition.
Topics: Anti-HIV Agents; Buprenorphine; Drug Interactions; Female; HIV Infections; Humans; Male; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Radioimmunoassay; Substance Abuse Detection; Time Factors; Zidovudine | 2001 |
Which substitution pharmacotherapy is most effective in treating opioid dependence?
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2002 |
Additional metabolic correlates of 1-alpha-acetylmethadol (LAAM)-induced cellular tolerance and physical dependence: the role of the hepatic microsomal electron transport system.
Topics: Animals; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Tolerance; Electron Transport; Enzyme Induction; Humans; Methadone; Methadyl Acetate; Mice; Mice, Inbred ICR; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Opioid-Related Disorders; Proteins | 1979 |
Effects of chronic treatment with morphine, methadone, and LAAM on the response to phencyclidine in rats.
Topics: Animals; Behavior, Animal; Drug Synergism; Humans; Male; Methadone; Methadyl Acetate; Morphine; Opioid-Related Disorders; Phencyclidine; Rats | 1979 |
Measurement of urine temperature as an alternative to observed urination in a narcotic treatment program.
Topics: Adult; Female; Humans; Male; Methadyl Acetate; Naltrexone; Narcotics; Opioid-Related Disorders; Specimen Handling; Temperature; Urine | 1979 |
Effectiveness of psychotherapeutic counseling in methadone maintenance.
Topics: Counseling; Double-Blind Method; Humans; Methadone; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Psychotherapy; Psychotherapy, Group | 1979 |
Development of cellular tolerance to lethality and analgesia concurrent with physical dependence following repeated oral administration of LAAM.
Topics: Administration, Oral; Animals; Drug Tolerance; Humans; Injections, Intraventricular; Lethal Dose 50; Male; Methadone; Methadyl Acetate; Mice; Mice, Inbred ICR; Morphine; Naloxone; Nociceptors; Opioid-Related Disorders | 1979 |
Divided dose for methadone maintenance patients.
Topics: Adrenergic alpha-Agonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 1988 |
Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
Topics: Adolescent; Adult; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders | 1986 |